Mutual of America Capital Management LLC Decreases Stock Position in Azenta, Inc. (NASDAQ:AZTA)

Mutual of America Capital Management LLC cut its holdings in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 73.9% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 6,903 shares of the company's stock after selling 19,535 shares during the period. Mutual of America Capital Management LLC's holdings in Azenta were worth $345,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Farther Finance Advisors LLC increased its position in Azenta by 20.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company's stock valued at $74,000 after purchasing an additional 256 shares during the period. KBC Group NV increased its position in shares of Azenta by 48.5% during the fourth quarter. KBC Group NV now owns 2,137 shares of the company's stock valued at $107,000 after buying an additional 698 shares during the period. Assenagon Asset Management S.A. bought a new position in Azenta in the fourth quarter worth about $200,000. Aigen Investment Management LP bought a new stake in Azenta during the 3rd quarter valued at approximately $214,000. Finally, Empowered Funds LLC purchased a new position in shares of Azenta during the 4th quarter worth approximately $293,000. Institutional investors own 99.08% of the company's stock.

Azenta Stock Performance

Shares of Azenta stock traded down $1.65 on Thursday, hitting $36.55. 805,670 shares of the company's stock were exchanged, compared to its average volume of 586,558. Azenta, Inc. has a 1 year low of $35.88 and a 1 year high of $65.09. The company has a 50-day simple moving average of $48.70 and a 200-day simple moving average of $47.22. The stock has a market capitalization of $1.67 billion, a PE ratio of -12.27 and a beta of 1.52.

Remove Ads

Azenta (NASDAQ:AZTA - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $0.08 EPS for the quarter, topping analysts' consensus estimates of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. On average, analysts expect that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have recently commented on the company. Stephens restated an "overweight" rating and issued a $60.00 target price on shares of Azenta in a research note on Thursday, January 2nd. TD Cowen raised shares of Azenta to a "hold" rating in a research report on Thursday, February 27th. Evercore ISI raised their price target on Azenta from $50.00 to $52.00 and gave the stock an "in-line" rating in a research note on Thursday, February 6th. Finally, Needham & Company LLC upped their price objective on Azenta from $55.00 to $59.00 and gave the company a "buy" rating in a research report on Thursday, February 6th. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $58.75.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.